SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-19-002603
Filing Date
2019-08-14
Accepted
2019-08-14 12:27:26
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM10-K AMENDMENT cannapharmarx_10ka-123118.htm 10-K/A 47391
2 CERTIFICATION cannapharmarx_10ka-ex3101.htm EX-31.1 9773
3 CERTIFICATION cannapharmarx_10ka-ex3102.htm EX-31.2 9441
4 CERTIFICATION cannapharmarx_10ka-ex032.htm EX-32 4191
  Complete submission text file 0001683168-19-002603.txt   72103
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27055 | Film No.: 191024590
SIC: 2834 Pharmaceutical Preparations